Results 41 to 50 of about 22,711 (279)

Self-Emulsifying Drug Delivery Systems: An Alternative Approach to Improve Brain Bioavailability of Poorly Water-Soluble Drugs through Intranasal Administration

open access: yesPharmaceutics, 2022
Efforts in discovering new and effective neurotherapeutics are made daily, although most fail to reach clinical trials. The main reason is their poor bioavailability, related to poor aqueous solubility, limited permeability through biological membranes ...
Sara Meirinho   +4 more
doaj   +1 more source

Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa

open access: yesPharmaceutics, 2018
The blood-brain barrier and the blood-cerebrospinal fluid barrier are major obstacles in central nervous system (CNS) drug delivery, since they block most molecules from entering the brain.
Stella Gänger, Katharina Schindowski
doaj   +1 more source

Intranasal drug delivery in pediatric emergency departments: brief review and future outlook [PDF]

open access: yesPediatric Emergency Medicine Journal, 2023
This review aims to provide an overview and update of current literature on the use of intranasal (IN) drug delivery in pediatric emergency medicine (PEM), in terms of the anatomy, physiology, pharmacokinetics, limitations, drug delivery methods ...
Christopher Hugh McClean   +4 more
doaj   +1 more source

Radiolabeled Risperidone microSPECT/CT Imaging for Intranasal Implant Studies Development

open access: yesPharmaceutics, 2023
The use of intranasal implantable drug delivery systems has many potential advantages for the treatment of different diseases, as they can provide sustained drug delivery, improving patient compliance.
Jon Ander Simón   +9 more
doaj   +1 more source

Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin

open access: yes, 2021
Carrier peptides, termed protein transduction domains (PTDs), serve as provide promising vehicles for intranasal delivery of macromolecular drugs. A mutant PTD derived from human translationally controlled tumor protein (TCTP-PTD 13, MIIFRALISHKK) was ...
이경림, 권영주
core   +2 more sources

Brain Targeting of Quetiapine Fumarate via Intranasal Delivery of Loaded Lipospheres: Fabrication, In-Vitro Evaluation, Optimization, and In-Vivo Assessment

open access: yesPharmaceuticals, 2022
A liposphere system for intranasal delivery of quetiapine fumarate (QTF) was created to assess the potential for enhanced drug delivery. We investigated the effects of particle size, entrapment effectiveness, poly dispersibility index, and pluronic ...
Randa Mohammed Zaki   +8 more
doaj   +1 more source

Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients

open access: yes, 2022
As a mental disease in modern society, depression shows an increasing occurrence, with low cure rate and high recurrence rate. It has become the most disabling disease in the world.
Zhang, Danshen   +13 more
core   +1 more source

Inhaled Insulin: Intrapulmonary or Intranasal?

open access: yes, 2012
Initial attempts delivered the insulin hormone intramuscularly, intravenously, and eventually subcutaneously. Other routes of administration of the drug were explored.
Shivangi Jaiswal   +3 more
core   +1 more source

Computational, In Vitro, and In Vivo Models for Nose-to-Brain Drug Delivery Studies

open access: yes, 2023
Direct nose-to-brain drug delivery offers the opportunity to treat central nervous system disorders more effectively due to the possibility of drug molecules reaching the brain without passing through the blood–brain barrier.
Radka Boyuklieva   +2 more
core   +1 more source

Solid Lipid Nanoparticles: A Potential Approach for Dermal Drug Delivery

open access: yes, 2014
Solid lipid nanoparticles (SLNs) have attracted increasing attention during recent years. Due to their unique size dependent properties, lipid nanoparticles offer possibilities to develop new therapeutics.
Conway, Barbara R   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy